This is my rendition of how the mark of the beast in Revelation 13:16–17 will control the food supply of the earth. “And he causeth all, both small and great…
At the viral chatter stage of an outbreak, pathogens are just starting to infect people in sporadic bursts. It’s a sign that a pandemic may be on the horizon.
Elon Musk Neuralink Implant: Neuralink’s Blindsight was designated as a ‘breakthrough device’ by the US FDA last year.
The European Center for Medium-Range Weather Forecasts (ECMWF) has fully operationalized its AI Forecasting System (AIFS), achieving up to 20% greater accuracy than traditional methods, particularly in tropical cyclone tracking.
• The process uses flash joule heating to mineralize PFAS, converting them into inert fluoride salts and upcycling waste carbon into high-value graphene.
• This innovative approach offers a cost-effective, scalable, and environmentally friendly solution to a pressing global problem.
• Meanwhile, scientists in Tokyo are exploring sustainable carbon-based materials and membrane distillation to remove PFAS, showcasing promising advancements in water purification technology.
These limits have kept solar tech stuck on rooftops and in fields. But a new type of cell, almost invisible to the eye, may soon change that. Transparent solar cells could turn windows, cars, and even skin into energy-harvesting surfaces.
Unlike the old models, these next-gen cells don’t clash with their surroundings. They blend in while still capturing sunlight. Some are so clear they reach up to 79% transparency. On average, most hover above 70%, allowing them to function without being noticed.
A major reason for this leap forward lies in materials only a few atoms thick. Known as 2D materials, they’re helping reshape what solar panels can do. One group, called transition metal dichalcogenides, absorbs light well and has band gaps that can be tuned.
Scientists unveil brain’s multi-dimensional network, offering new insights into memory storage and processing
Scientists at Wenzhou Medical University and Xiamen University have shown how autism symptoms in mice arise when a certain pair of competing nerve proteins falls out of equilibrium. The results of the team’s study, reported in PLOS Biology could point to potential therapeutic approaches for autism spectrum disorder (ASD). In their paper, titled “Mdfa2 deficiency leads to an aberrant activation of BDNF/TrkB signaling that underlies autism-relevant synaptic and behavioral changes in mice,” research leads Dongdong Zhao, PhD, at Wenzhou Medical University, and Yun-wu Zhang, PhD, at Xiamen University, and colleagues concluded that their findings “highlight a novel MDGA2-BDNF/TrkB-dependent mechanism underlying the synaptic function regulation, which may become a therapeutic target for ASD.”
Autism spectrum disorder is a complex neurodevelopmental disorder with its onset in early childhood, the authors noted. The disorder is characterized by reduced social interaction, increased stereotypic repetitive behavior, and altered cognition. “The prevalence of ASD has increased significantly in recent years, with approximately 1% of the world population considered to have the disorder,” the team noted. “Despite growing efforts devoted to this field, the etiology of ASD has yet to be fully elucidated.”
Previous research has linked certain genetic factors to ASD, including many associated with neuron activity, but it remains unclear exactly how these factors are related. “So far, identified genes only explain a portion of ASD occurrence,” the investigators continued. “Identifying additional ASD-associated genes and revealing the underlying mechanisms should provide new insights into the pathogenesis of ASD and its treatment strategies.”
Large-scale analyses of electronic health data suggest that the herpes zoster vaccine could protect against dementia — but it’s not yet clear how.